Devaleryl Valsartan Impurity

• Description:

  Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Drug Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/devaleryl-valsartan-impurity.html

• Purity:

  99.98

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  CC(C)[C@@H](C(O)=O)NCC1=CC=C(C2=CC=CC=C2C3=NNN=N3)C=C1

• Molecular Formula:

  C19H21N5O2

• Molecular Weight:

  351.41

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]A Sampath, et al. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist. J Pharm Biomed Anal. 2009 Oct 15;50 (3) :405-12.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [676129-92-3]